The Headlines – Pharma growth: AstraZeneca profit surges 77% to $2.53 bn in Q3; US expansion and cancer drugs power strong results

AstraZeneca reported a significant 77% surge in quarterly net profit, reaching $2.53 billion, driven by strong US growth and robust sales of its cancer drugs. The pharmaceutical giant’s revenue climbed 12% to $15.2 billion, with oncology treatments now comprising nearly 44% of its total income. This performance underscores the company’s strategic focus on expanding its US operations and manufacturing footprint.

The Headlines – Business News Today: Stock Markets, Financial News, India Business & World Business News – Read More